Literature DB >> 34750158

ANCA Vasculitis Treatment in the Dialysis Patient: Caution Needed!

Elizabeth Hendren1, Jai Radhakrishnan2.   

Abstract

Entities:  

Keywords:  antineutrophil cytoplasmic antibodies; renal dialysis; vasculitis

Mesh：

Substances：

Year:  2021        PMID： 34750158      PMCID： PMC8729427          DOI： 10.2215/CJN.11960921

Source DB:  PubMed          Journal:  Clin J Am Soc Nephrol        ISSN： 1555-9041            Impact factor:   8.237


× No keyword cloud information.
  9 in total

1.  Chances of renal recovery for dialysis-dependent ANCA-associated glomerulonephritis.

Authors:  Robert A F de Lind van Wijngaarden; Herbert A Hauer; Ron Wolterbeek; David R W Jayne; Gill Gaskin; Niels Rasmussen; Laure-Hélène Noël; Franco Ferrario; Rüdiger Waldherr; Jan A Bruijn; Ingeborg M Bajema; E Christiaan Hagen; Charles D Pusey
Journal:  J Am Soc Nephrol       Date:  2007-07       Impact factor: 10.121

2.  Alternative complement pathway activation products in urine and kidneys of patients with ANCA-associated GN.

Authors:  Shen-Ju Gou; Jun Yuan; Chen Wang; Ming-Hui Zhao; Min Chen
Journal:  Clin J Am Soc Nephrol       Date:  2013-10-10       Impact factor: 8.237

3.  Plasma Exchange and Glucocorticoids in Severe ANCA-Associated Vasculitis.

Authors:  Michael Walsh; Peter A Merkel; Chen-Au Peh; Wladimir M Szpirt; Xavier Puéchal; Shouichi Fujimoto; Carmel M Hawley; Nader Khalidi; Oliver Floßmann; Ron Wald; Louis P Girard; Adeera Levin; Gina Gregorini; Lorraine Harper; William F Clark; Christian Pagnoux; Ulrich Specks; Lucy Smyth; Vladimir Tesar; Toshiko Ito-Ihara; Janak Rashme de Zoysa; Wojciech Szczeklik; Luis Felipe Flores-Suárez; Simon Carette; Loïc Guillevin; Charles D Pusey; Alina L Casian; Biljana Brezina; Andrea Mazzetti; Carol A McAlear; Elizabeth Broadhurst; Donna Reidlinger; Samir Mehta; Natalie Ives; David R W Jayne
Journal:  N Engl J Med       Date:  2020-02-13       Impact factor: 91.245

4.  Avacopan for the Treatment of ANCA-Associated Vasculitis.

Authors:  David R W Jayne; Peter A Merkel; Thomas J Schall; Pirow Bekker
Journal:  N Engl J Med       Date:  2021-02-18       Impact factor: 91.245

5.  Disease Activity and Adverse Events in Patients with ANCA-Associated Vasculitides Undergoing Long-Term Dialysis.

Authors:  Maëlis Kauffmann; Mickaël Bobot; Thomas Robert; Stéphane Burtey; Grégoire Couvrat-Desvergnes; Frédéric Lavainne; Xavier Puéchal; Benjamin Terrier; Thomas Quéméneur; Stanislas Faguer; Alexandre Karras; Philippe Brunet; Cécile Couchoud; Noémie Jourde-Chiche
Journal:  Clin J Am Soc Nephrol       Date:  2021-11       Impact factor: 8.237

6.  Survival of patients with ANCA-associated vasculitis on chronic dialysis: data from the French REIN registry from 2002 to 2011.

Authors:  M Romeu; C Couchoud; J-C Delarozière; S Burtey; L Chiche; J-R Harlé; B Gondouin; P Brunet; Y Berland; N Jourde-Chiche
Journal:  QJM       Date:  2014-02-24

7.  The outcomes of patients with ESRD and ANCA-associated vasculitis in Australia and New Zealand.

Authors:  Wen Tang; Bhadran Bose; Stephen P McDonald; Carmel M Hawley; Sunil V Badve; Neil Boudville; Fiona G Brown; Philip A Clayton; Scott B Campbell; Chen Au Peh; David W Johnson
Journal:  Clin J Am Soc Nephrol       Date:  2013-01-24       Impact factor: 8.237

8.  The clinical course of ANCA small-vessel vasculitis on chronic dialysis.

Authors:  Sofia Lionaki; Susan L Hogan; Caroline E Jennette; Yichun Hu; Julie B Hamra; J Charles Jennette; Ronald J Falk; Patrick H Nachman
Journal:  Kidney Int       Date:  2009-06-17       Impact factor: 10.612

9.  Complications of Immunosuppression in Glomerular Disease.

Authors:  J Ashley Jefferson
Journal:  Clin J Am Soc Nephrol       Date:  2018-07-24       Impact factor: 8.237
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.